Related Experiment Videos

Rejoinder to "A hybrid phase I-II/III clinical trial design allowing dose reoptimization in phase III"

Andrew G Chapple1, Peter F Thall2

  • 1Biostatistics Program, School of Public Health, Louisiana State University, New Orleans, Louisiana.

Biometrics
|June 28, 2019
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos